Achiko AG issues a convocation notice to its shareholders for its Annual General Meeting on 20 December 2022 - Seite 2

The invitation to the Annual General Meeting of Achiko, containing the full agenda, the proposals of the Board of Directors as well as further information, is available as of today at https://www.achiko.com/financials.
 

ABOUT ACHIKO AG 

Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com) is developing disruptive diagnostic solutions that put people first. The Company’s lead product, AptameX, is a rapid, reliable Covid-19 test with a companion app, Teman Sehat, offering a user-friendly digital health passport.  AptameX and Teman Sehat were launched in Indonesia in mid-2021 and AptameX received the CE Mark in the European Union in May 2022.  

The AptameX DNA aptamer tests can be rapidly chemically synthesised, are cost-effective, easily scalable and have broad potential across multiple disease areas. Achiko aims to deliver fast, accurate and affordable diagnostic testing for a range of diseases in the rapidly evolving healthcare diagnostics field.  

Headquartered in Zurich, Achiko has offices in Jakarta, and staff around the world. 
 

Media contacts:  

ACHIKO AG
Investor Relations
E: [e-mail]

Switzerland & Global
Marcus Balogh
Farner Consulting Ltd
E: [e-mail]
T: [phone]

Disclaimer 
This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. In consequence, no undue reliance should be placed on these forward-looking statements by investors. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise